Other
Safety and Efficacy
0
Pipeline Programs↗
225
Active Trials↗
319
Companies Involved↗
Safety and Efficacy is an early-stage landscape with 0 programs across 319 companies. The most active players are Novartis, Pfizer, Gilead.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
1,758
clinical trials
Completed1,111 · 63%
Unknown status183 · 10%
Terminated170 · 10%
Recruiting130 · 7%
Withdrawn58 · 3%
Active, not recruiting56 · 3%
Other50 · 3%
Clinical Trials
Trial Activity
1758 trials
The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT
Recruiting·—·Phase 1·NCT06558253·12 enrolled
Metformin in Safety and Efficacy in Gouty Patients
Recruiting·—·Phase 2·NCT06924658·70 enrolled
Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML
Recruiting·—·Phase 2·NCT06741722·20 enrolled
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
Recruiting·—·Phase 2·NCT05695261·37 enrolled
Page 1 of 118
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)